Jones Hill Capital LP

NEW YORK, NY · Quarter end: Sep 30, 2026 · Filed with SEC: Nov 13, 2026 · Open the SEC source ↗
Portfolio Return (1Y)——
Portfolio Value (AUM)Total value of the fund's US stock portfolio reported to the SEC.$589.2M2026 Q3
Positions33
Top-10 ConcentrationPercent of the portfolio in the 10 largest holdings. High means the fund is concentrated in few stocks.68.1%

Jones Hill Capital LP reported 33 positions worth $589.2M as of September 30, 2026 (13F filed November 13, 2026). Largest holding: BMRN (11.9%).

10 / 33 positions shown
#SymbolCompanyValue ↓% Port.Shares1YYTDSince reported
▸ 1 BMRNBiomarin Pharmaceutical$70.3M11.93%1,171,859——-3.3%
▸ 2 BCRXBiocryst Pharmaceuticals$59.0M10.02%7,083,300——-8.6%
▸ 3 TVTXTravere Therapeutics$56.5M9.59%959,634——-15.6%
▸ 4 INDVSupernus$54.7M9.29%1,526,685——+1.2%
▸ 5 PHVSPharvaris N.V.$31.3M5.32%987,637——+2.3%
▸ 6 CELCCelcuity$30.4M5.17%382,901——-23.8%
▸ 7 IONSIonis Pharmaceuticals$26.8M4.55%599,826——-37.3%
▸ 8 SUPNSupernus$25.9M4.39%601,685——-33.0%
▸ 9 NUVBNuvation Bio$25.1M4.26%4,486,986——-31.4%
▸ 10 VERAVera Therapeutics$21.1M3.58%652,218——-13.0%

Pro Feature

The remaining 23 positions with Pro.

Upgrade to Pro

Read the 2026-Q2 quarterly report · 13F Filing Calendar

🔔 Tell me when this fund files a new 13F

No account needed: in your inbox the morning it is published.

Frequently Asked Questions

What stocks does Jones Hill Capital LP hold as of Q3 2026?

Jones Hill Capital LP reported 33 positions worth $589.2M in its Q3 2026 13F filing. Largest positions: BMRN (11.9%), BCRX (10.0%), TVTX (9.6%), INDV (9.3%) and PHVS (5.3%).

What did Jones Hill Capital LP buy in Q3 2026?

No previous quarter is available yet; the comparison appears with the next filing.

What did Jones Hill Capital LP sell in Q3 2026?

No previous quarter is available yet.

13F data shows quarter-end positions, is delayed by up to 45 days and covers only long positions in US-listed securities; short positions, most derivatives and non-US assets are not reported.